CLPT | ClearPoint NeuroNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$9.95
-$0.72 (-6.75%)

ClearPoint Neuro (CLPT) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2021.

The 50 SMA has sat below the 200 on the daily since Oct 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits below the 50 and the 200 on the daily, the weekly and the 4-hour.

Timeframe summary

Daily as of 2 Nov 16:00 ET

Price
below both $9.95 vs 50 $12.40 / 200 $12.94
Projection
No cross projected
Test
Cross test window open, no test bar yet
Last cross
Death cross 23 Oct 2026 ยท projected 25 bars out

Weekly as of 30 Oct 16:00 ET

Price
below both $10.67 vs 50 $13.18 / 200 $10.84
Projection
Death cross estimated 15+ weeks out
Test
No active test
Last cross
Golden cross week of 3 Mar 2025 ยท projected 26 bars out ยท tested 4 bars

4-hour as of 3 Nov 16:00 ET

Price
below both $9.71 vs 50 $10.12 / 200 $14.03
Projection
No cross projected
Test
No active test
Last cross
Death cross 25 Sep 2026 bar 2 ยท projected 28 bars out ยท tested 2 bars

Cross history

24
crosses on record since 2021
12 golden12 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
23 Oct 2026Death steepdaily25 bars outActive Cross Test
25 Sep 2026Death4-hour28 bars out2 bar cross test
22 Jul 2026Golden moderatedaily30 bars out5 bar cross test
4 Jun 2026Golden4-hour14 bars outNot tested
21 Jan 2026Death steepdaily28 bars out5 bar cross test

About CLPT

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$7.4M
4-hour coverageYes, since Oct 2025
History on recordSince 2021
SectorHealthcare
Cap bandsmall

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.